Testing effectiveness (Phase 2)Active Not RecruitingNCT06663176
What this trial is testing
Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)
Who this might be right for
Non-Cystic Fibrosis Bronchiectasis
Thirty Respiratory Limited 60